Posted in | News | Nanofluidics | Nanobusiness

Nanogen Expands Partnership with HandyLab

Nanogen, Inc., developer of molecular and rapid diagnostic products, announced today that it has expanded its partnership with HandyLab, Inc. by signing a licensing and supply agreement for use of the company's proprietary Minor Groove Binder (MGB) Probe technology and synthetic nucleic acid chemistries, including dyes and quenchers, for use in in vitro diagnostic testing.

Under the licensing agreement, HandyLab receives a non-exclusive license to market, sell and distribute PCR test kits utilizing Nanogen's patented technology for use on HandyLab's Jaguar System and other HandyLab systems. Terms of the agreement include an upfront license fee and a commitment to supply HandyLab with Nanogen's proprietary PCR products.

“Our proprietary MGB technology continues to be the cornerstone for many real-time PCR assays in the rapidly expanding molecular diagnostics market,” said David Ludvigson, Nanogen's President and Chief Operating Officer. “HandyLab will use our PCR products together with their automated testing platform to provide a complete testing solution for molecular laboratories.”

“HandyLab is excited to pair our novel Jaguar automated nucleic acid test system with Nanogen's proven MGB chemistry technology,” said Jeff Williams, President and Chief Executive Officer of HandyLab. “This agreement positions us as a fully integrated company with a unique solution for the molecular diagnostic market.”

This licensing agreement marks the expansion of an already established partnership. In 2008, the U.S. Centers for Disease Control and Prevention (CDC) awarded a $10.4 million, two-year contract to Nanogen for the development of a multi-analyte molecular diagnostic assay for Influenza. The Influenza test is being developed for use with the HandyLab microfluidic real-time PCR Raider instrument.

Nanogen's MGB technology is licensed broadly in various fields and is now an integral component in thousands of PCR probe products. Nanogen has more than 35 reagent and kit products that are sold for clinical diagnostic use under the MGB Alert and Q-PCR Alert brands.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanogen. (2019, February 14). Nanogen Expands Partnership with HandyLab. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=10111.

  • MLA

    Nanogen. "Nanogen Expands Partnership with HandyLab". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=10111>.

  • Chicago

    Nanogen. "Nanogen Expands Partnership with HandyLab". AZoNano. https://www.azonano.com/news.aspx?newsID=10111. (accessed November 21, 2024).

  • Harvard

    Nanogen. 2019. Nanogen Expands Partnership with HandyLab. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=10111.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.